TIAPRIDAL 138 mg/ml, oral solution bottle, 30 ml
Active ingredients: Tiapride hydrochloride, Tiapride
Commercialized according to BDPMDispensing in France: Prescription only
Oral solutionbottle, 30 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TIAPRIDAL 138 mg/ml, solution buvable
- Pharmaceutical form
- solution buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre brun de 30 ml avec fermeture de sécurité enfant et une seringue(s) pour administration orale en polyéthylène/polystyrène
- Marketing authorisation holder
- NEURAXPHARM FRANCE
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 14 Jun 1999
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68673220CIP73461109CIP133400934611094Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE TIAPRIDEsolution | 15,321 g · 100 ml | SA |
| TIAPRIDE BASEsolution | 13,790 g · 100 ml | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.